semaglutide shortage resolved fda declaratory order february 21 2025 The FDA has issued a warning to Compounded Semaglutide & Tirzepatide 2025: – End of Semaglutide Shortage Means

Injection site reactions, persistent heartburn, and severe constipation affect a subset of tirzepatide users disproportionately

Both decisions were correct

Inagaki N, Takeuchi M, Oura T, Imaoka T, Seino Y (2022) Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

Check the syringe packaging or the barrel of the syringe itself

Drug-induced depression: a systematic review to inform clinical practice

If You Hit a Plateau If your weight hasnt changed in the direction you want for about two weeks, you've likely hit a plateau